Research Outputs (37)

Sort by: Date | Title

10 | 25 | 50 | 100

1/4

A B C D E F G H I L M N O P Q R S T U V Z 中促 All

Association Between SRD5A1 gene and Hepatocellular Carcinoma in Chinese male Hepatitis B carriers
TANG Leung Sang Nelson, LIAO Chen Di, JIANG Jieying, WANG Xingyan, QIU Yuqing, TSAI S Peter, YEO Winnie, HUI Pun Edwin, CHAN Lam Stephen, LAM Kwok Chi, HO Ming Wing, LAI Bo San Paul ( 2010 )
5th Sino-US Conference Personalized Medicine in Cancer Therapy in conjunction with the 15th Annual Scientific Symposium of the Hong Kong Cancer Institute
Other conference paper
Assessment of tumor size and tumour response for nasopharyngeal carcinoma (NPC): Implication of different methods of assessment for an Irregular shaped tumor.
Zee BC, King AD, Yuen E, Ma B, Leung SF, Yeung D, Kam M, Chan A, Ahuja AT ( 2005 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
Assessment of liver dysfunction in hepatocellular carcinoma (HCC): An international collaborative study.
Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng MJ, Skowronska A, Cox TF, Palmer DH, Yeo W, Mo F, Lai PBS, Inarrairaegui M, Chan SL, Sangro B, Tada T, Toyoda H, Kumada T ( 2014 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
Assessing Prognosis before Surgical Resection in Osteosarcoma
LIN Joanna, LEUNG Wai Tong Thomas, S. Ho, KUMTA Shekhar Madhukar, METREWELI Constantine, JOHNSON Philip James ( 1995 )
Proceedings of the Joint Meeting of the European and American Musculoskeletal Tumour Society and the 8th International Symposium on Limb Salvage
Other conference paper
A simple score using hepatitis B virus DNA can predict development of hepatocellular carcinoma in 10 years
CHAN Lik Yuen Henry, WONG Wai Sun Vincent, MO Kwok Fai, CHAN Lam Stephen, MOK Shu Kam Tony ( 2010 )
Health Research Symposium 2010: Improving Health and Recognising Excellence
Other conference paper
A scoring system in predicting the risk of hepatocellular carcinoma in chronic hepatitis B carrier
Chan SL, Mo F, Wong VW, Wong GL, Loong HH, Chan V, Chan AT, Yeo W, Chan HL, Mok T ( 2009 )
EJC SUPPLEMENTS
Other conference paper
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S1359-6349(09)71238-8
A RANDOMIZED PHASE (PH) 2 STUDY WITH EXPLORATORY BIOMARKER ANALYSIS OF FICLATUZUMAB (F) A HUMANIZED HEPATOCYTE GROWTH FACTOR (HGF) INHIBITORY MAB IN COMBINATION WITH GEFITINIB (G) VERSUS G IN ASIAN PATIENTS (PTS) WITH LUNG ADENOCARCINOMA (LA)
Mok TSK, Park K, Geater SL, Agarwal S, Han M, Credi M, McKee K, Kuriyama N, Slichenmyer W, Tan EH ( 2012 )
ANNALS OF ONCOLOGY
Other conference paper
A randomized phase II study of concurrent cisplatin-radiotherapy (RT) with or without neoadjuvant chemotherapy using docetaxel and cisplatin in advanced nasopharyngeal carcinoma (NPC).
Chan AT, Hui EP, Ma B, Leung SF, King A, Mo F, Lai M, Yu KH, Kwan WH, Zee B ( 2005 )
JOURNAL OF CLINICAL ONCOLOGY
Other conference paper
A randomized phase II study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
Yeo W, Mo FKF, Suen JJS, Ho WM, Chan SL, Yeung WK, Lau W, Lee KKC, Kwan WH, Zee B ( 2008 )
EJC SUPPLEMENTS
Other conference paper
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S1359-6349(08)70813-9
A randomised control clinical trial to assess the impact of enhanced geriatric input on elderly patients undergoing colorectal cancer surgery
T. Mak, D. Dai, J. Lee, B. Ma, W. Leung, S. Ng ( 2017 )
Other conference paper

10 | 25 | 50 | 100

1/4

Research Outputs (37)

Share Link

Our policy towards the use of cookies